Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etofylline clofibrate adjunctive therapy in Parkinson's disease with motor fluctuations
CTR20190177Phase 3Active
- Sponsor
- CSPC Pharmaceutical Group
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of etofibrate in Parkinson's disease (PD), sponsored by CSPC Pharmaceutical Group. Started Feb 2019; status: active.
02
Drugs
etofibrate
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on CTR20190177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190177.